Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. bras. cir. cardiovasc ; 34(6): 749-758, Nov.-Dec. 2019. tab, graf
Article in English | LILACS | ID: biblio-1057489

ABSTRACT

Abstract Objective: In our clinic, we aimed to investigate the effect of preoperative risk factors and postoperative complications on reoperation and mortality in cases with Behçet's disease which presents very rare coronary artery involvement. Methods: Thirteen patients with Behçet's Disease who had undergone coronary artery bypass grafting in our center between 2003 and 2015 were analyzed. We evaluated the clinical and laboratory findings, complications and mortality rates of our patients in light of the literature. Results: The mean age was 38.5 (30-55; 3 women). The mean time from onset of Behçet's disease to coronary artery disease was 4,7 (3-11) years. Fifty-four percent of the patients were asymptomatic. Coronary artery disease of these was exposed while peripheral vascular surgery was planned due to complications of Behçet's disease. Symptomatic patients presented angina pectoris (31%), acute coronary syndrome (8%) and arrhythmia (8%). In coronary pathology of patients, distal type obstruction (31%), aneurysm and pseudoaneurysm (31%), proximal segment thrombus (15%), chronic type stenosis and occlusions (31%) were present. Early mortality (15%) was due to acute myocardial infarction while the late mortality (15%) was due to cerebral and gastrointestinal bleeding. Reoperation was due to bleeding in one case on the 1st postoperative day and due to acute pulmonary embolism in another case in the 3rdpostoperative year. Conclusion: In Behçet's disease, coronary artery bypass grafting is a procedure with high mortality, especially in the acute period. The on-pump surgery technique in these cases can be safely performed for multiple bypasses and in patients above 40 years old.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Coronary Artery Disease/etiology , Coronary Artery Bypass/adverse effects , Behcet Syndrome/complications , Postoperative Complications , Prognosis , Behcet Syndrome/surgery , Behcet Syndrome/mortality , Risk Factors , Aneurysm, False/etiology , Coronary Vessels/surgery , Rare Diseases , Preoperative Period
2.
Clinics ; 71(6): 302-310, tab, graf
Article in English | LILACS | ID: lil-787419

ABSTRACT

OBJECTIVES: Behcet’s disease is a form of systematic vasculitis that affects vessels of various sizes. Aortic pseudoaneurysm is one of the most important causes of death among patients with Behcet’s disease due to its high risk of rupture and associated mortality. Our study aimed to investigate the outcomes of Behcet’s disease patients with aortic pseudoaneurysms undergoing open surgery and endovascular aortic repair. METHODS: From January 2003 to September 2014, ten consecutive patients undergoing surgery for aortic pseudoaneurysm met the diagnostic criteria for Behcet’s disease. Endovascular repair was the preferred modality and open surgery was performed as an alternative. Systemic immunosuppressive medication was administered after Behcet’s disease was definitively diagnosed. RESULTS: Eight patients initially underwent endovascular repair and two patients initially underwent open surgery. The overall success rate was 90% and the only failed case involved the use of the chimney technique to reach a suprarenal location. The median follow-up duration was 23 months. There were 7 recurrences in 5 patients. The median interval between operation and recurrence was 13 months. No significant risk factors for recurrence were identified, but a difference in recurrence between treatment and non-treatment with preoperative immunosuppressive medication preoperatively was notable. Four aneurysm-related deaths occurred within the follow-up period. The overall 1-year, 3-year and 5-year survival rates were 80%, 64% and 48%, respectively. CONCLUSIONS: Both open surgery and endovascular repair are safe and effective for treating aortic pseudoaneurysm in Behcet’s disease patients. The results from our retrospective study indicated that immunosuppressive medication was essential to defer the occurrence and development of recurrent aneurysms.


Subject(s)
Humans , Male , Adult , Middle Aged , Behcet Syndrome/surgery , Aortic Aneurysm, Abdominal/surgery , Aneurysm, False/surgery , Endovascular Procedures/methods , Postoperative Period , Recurrence , Time Factors , Behcet Syndrome/complications , Behcet Syndrome/mortality , Survival Rate , Retrospective Studies , Treatment Outcome , Aortic Aneurysm, Abdominal/etiology , Aortic Aneurysm, Abdominal/mortality , Aortic Aneurysm, Abdominal/drug therapy , Aneurysm, False/etiology , Aneurysm, False/mortality , Aneurysm, False/drug therapy , Blood Vessel Prosthesis Implantation/methods , Immunosuppressive Agents/therapeutic use
3.
Saudi Medical Journal. 2006; 27 (11): 1754-1757
in English | IMEMR | ID: emr-80660

ABSTRACT

Behcet's disease BD may involve in any large or small artery, vein. We present a case of BD with multiple venous thromboses, cardiac and pulmonary involvements, and renal failure. A 22-year-old man admitted with progressive dyspnea and edema on his face and neck. He had the history of recurrent oral and genital ulcers, and pustular skin lesions for 4 years. Doppler ultrasonography revealed right internal jugular vein thrombosis. Transthoracic echocardiography showed a pericardial effusion, decreased left ventricular ejection fraction. While his symptoms were regressing moderately with a pulse cyclophosphamide, prednisolone, and low molecular weight heparin treatment, new thromboses occurred in vena cava inferior, and bilateral renal veins after the third and 7th dosages of pulse cyclophosphamide. Creatinine levels increased progressively, which required hemodialysis. However, he died after the second session of hemodialysis. Patients with BD should be followed up for new developing thrombosis even during an immunosuppressive treatment


Subject(s)
Humans , Male , Behcet Syndrome/mortality , Renal Dialysis , Renal Veins , Venous Thrombosis/drug therapy , Venous Thrombosis/diagnostic imaging , Vena Cava, Inferior , Creatinine/blood
SELECTION OF CITATIONS
SEARCH DETAIL